Trials / Conditions / Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
6 registered clinical trials studyying Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/G NCT07023315 | Akeso | Phase 3 |
| Recruiting | Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Canc NCT07026149 | Ruijin Hospital | Phase 2 |
| Recruiting | Pan-tumor MRD Study NCT06605404 | Paradigm Health | — |
| Active Not Recruiting | Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer NCT06693128 | Ruijin Hospital | Phase 2 |
| Active Not Recruiting | A Study of NDI 1150-101 in Patients With Solid Tumors NCT05128487 | Nimbus Saturn, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer NCT04208347 | Ruijin Hospital | Phase 2 / Phase 3 |